A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma

Clinical trial NCT02550678 · COMPLETED

Trial details

NCT number: NCT02550678
Sponsor: Ascend Biopharmaceuticals Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Basal Cell Nevus Syndrome Skin Neoplasm Nodular Basal Cell Carcinoma of Skin

Start date: 2015-09-01
Primary completion: 2017-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.